FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
dextrose, sodium chloride, sodium acetate anhydrous, sodium gluconate, potassium chloride, and magnesium chloride
LOE Approaching
Otsuka
INJECTION · INJECTABLE
1975
NDA
30/100
NORMOSOL-R IN PLASTIC CONTAINER
sodium chloride, sodium acetate anhydrous, sodium gluconate, potassium chloride, and magnesium chloride
LOE Approaching
Otsuka
INJECTION · INJECTABLE
1975
NDA
30/100
NORMOZIDE
hydrochlorothiazide; labetalol hydrochloride
LOE Approaching
Merck & Co.
ORAL · TABLET
1987
NDA
30/100
NOROXIN
norfloxacin
LOE Approaching
Merck & Co.
ORAL · TABLET
1986
SMNDA
30/100
NORPACE
disopyramide phosphate
LOE Approaching
Pfizer
ORAL · CAPSULE
documented ventricular arrhythmiassuch+2
1977
NDA
30/100
NORPACE CR
disopyramide phosphate
LOE Approaching
Pfizer
ORAL · CAPSULE, EXTENDED RELEASE
documented ventricular arrhythmiassuch+2
1982
NDA
30/100
NORPLANT
levonorgestrel
LOE Approaching
Medica Corp
IMPLANTATION · IMPLANT
1990
NDA
30/100
NORPLANT SYSTEM IN PLASTIC CONTAINER
levonorgestrel
LOE Approaching
Pfizer
IMPLANTATION · IMPLANT
1990
NDA
30/100
NORPRAMIN
desipramine hydrochloride
LOE Approaching
Bausch Health
ORAL · TABLET
depression
1964
NDA
30/100
NORQUEST FE
ethinyl estradiol; ferrous fumarate; norethindrone
LOE Approaching
Pfizer
ORAL-28 · TABLET
1986
NDA
30/100
NORTHERA
droxidopa
Peak
ORAL · CAPSULE
orthostatic dizzinesslightheadedness+5
2014
NDA
30/100
NORVASC
amlodipine besylate
LOE Approaching
Viatris (2)
ORAL · TABLET
hypertensionto lower blood pressure+4
1992
NDA
30/100
NORVIR
ritonavir
LOE Approaching
AbbVie
ORAL · TABLET
2010
SMNDA
30/100
NORVIR
ritonavir
Peak
AbbVie
ORAL · POWDER
2017
SMNDA
30/100
NORVIR
ritonavir
LOE Approaching
AbbVie
ORAL · SOLUTION
combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1 infection
1996
SMNDA
30/100
NORVIR
ritonavir
LOE Approaching
AbbVie
ORAL · CAPSULE
combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1 infection
1999
SMNDA
30/100
NORVIR
ritonavir
LOE Approaching
Abbott
ORAL · CAPSULE
combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1 infection
1996
SMNDA
30/100
NOVAFED
pseudoephedrine hydrochloride
LOE Approaching
Sanofi
ORAL · CAPSULE, EXTENDED RELEASE
1975
NDA
30/100
NOVAMINE 11.4%
amino acids
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1978
NDA
30/100
NOVAMINE 15%
amino acids
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1978
NDA
30/100
NOVAMINE 15% SULFITE FREE IN PLASTIC CONTAINER
amino acids
LOE Approaching
Baxter
INJECTION · INJECTABLE
1993
NDA
30/100
NOVAMINE 8.5%
amino acids
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1978
NDA
30/100
NOVANTRONE
mitoxantrone hydrochloride
LOE Approaching
INJECTION · INJECTABLE
1987
NDA
30/100
NOVANTRONE
mitoxantrone hydrochloride
LOE Approaching
INJECTION · INJECTABLE
2000
NDA
30/100
← PreviousPage 123 of 277Next →